Vilaprisan clinical trials
Also written BAY1002670.
How each study uses vilaprisan is sorted by a rule, right about nine times in ten. Readers can ask us to read every study one by one.Ask us to read each study
Approvals
The first approval found in each region, with its record
- United States
- Not in FDA's approval records
- European Union
- Not in EMA's list of EU-wide authorizations
From FDA's Drugs@FDA and Purple Book (through openFDA) and the European Medicines Agency, files of Sept 2026 and 27 Oct 2026. National approvals in Europe and other countries are not included. How this is worked out
How studies write it
Studies that test it under each name
Studies by the year they started
16 studies that test it; most in 2018 (6)
| Year | Studies |
|---|---|
| 2011 | 1 |
| 2014 | 2 |
| 2015 | 2 |
| 2017 | 5 |
| 2018 | 6 |
By phase
A phase 1/2 study counts in both.
What it is tested for
Each study’s main condition, where its own words name it, so a study counts once.
Who runs them
Industry 16 · Other 0
Studies
Open first, then newest update. How each study uses vilaprisan is read from its arms, and is right about nine times in ten. Ask us to read each study. These are the studies that list it as an intervention; a search of ClinicalTrials.gov also finds studies that mention it only in a description, such as earlier treatment.
Testing it · 16
- Assess Safety and Efficacy of Vilaprisan in Subjects With Uterine FibroidsTerminatedPhase 3BayerNCT03194646Written as Vilaprisan (BAY1002670)
- A Study to Assess Safety and Efficacy of Vilaprisan in Subjects With Uterine FibroidsTerminatedPhase 3BayerNCT03240523Written as Vilaprisan (BAY1002670)
- Assess Safety and Efficacy of Vilaprisan in Subjects With Uterine Fibroids (ASTEROID 3)TerminatedPhase 3BayerNCT03400943Written as Vilaprisan (BAY1002670)
- A Study to Assess the Safety and Efficacy of Vilaprisan in Japanese Subjects With Uterine Fibroids and Heavy Menstrual BleedingTerminatedPhase 3BayerNCT03476928Written as Vilaprisan (BAY1002670)
- Assess Safety and Efficacy of Vilaprisan in Subjects With Uterine Fibroids (ASTEROID 4)TerminatedPhase 3BayerNCT03400956Written as Vilaprisan (BAY1002670)
- Assess Safety and Efficacy of Vilaprisan in Subjects With EndometriosisTerminatedPhase 2BayerNCT03573336Written as Vilaprisan (BAY1002670)
- Mode of Action Study of Vilaprisan and Ulipristal Acetate in Patients With Uterine Fibroids for Whom Surgery is PlannedTerminatedPhase 1BayerNCT03342859Written as Vilaprisan, BAY1002670
- Assessment of Safety and Efficacy of Vilaprisan in Subjects With Uterine FibroidsWithdrawnPhase 3BayerNCT03699176Written as Vilaprisan (BAY1002670)
- Pharmacokinetics and Safety of Vilaprisan in Renal ImpairmentCompletedPhase 1BayerNCT03411980Written as Vilaprisan (BAY1002670)
- Drug-drug Interaction Study: Influence of Vilaprisan on Pharmacodynamics (PD) and Pharmacokinetics (PK) of a Combined Oral Contraceptive (COC)CompletedPhase 1BayerNCT03210246Written as Vilaprisan (BAY 1002670)
- Bay1002670, Fibroids, Safety and Efficacy EU,US,Can, JapCompletedPhase 2BayerNCT02131662Written as BAY1002670
- Effect of Hepatic Impairment on the Pharmacokinetics, Safety and Tolerability of BAY1002670 (Vilaprisan)CompletedPhase 1BayerNCT03092999Written as Vilaprisan (BAY1002670)
- Assess Safety and Efficacy of Vilaprisan in Patients With Uterine FibroidsCompletedPhase 2BayerNCT02465814Written as Vilaprisan (BAY1002670)
- Study in Healthy Young Women to Investigate the Pharmacodynamics, Pharmacokinetics and Safety of VilaprisanCompletedPhase 1BayerNCT02262663Written as Vilaprisan (BAY1002670)
- Study in Postmenopausal Women to Investigate the Drug-drug Interaction (DDI) Between Itraconazole(ITZ) and Orally Administered Vilaprisan; Absolute Bioavailability Using Intravenous Microtracer Dose of [14C]VilaprisanCompletedPhase 1BayerNCT02456129Written as Vilaprisan (BAY1002670)
- Study in Healthy Tubal Ligated Women to Evaluate Pharmacodynamics, Safety and Pharmacokinetics of BAY1002670CompletedPhase 1BayerNCT01816815Written as BAY1002670
Codes
What other systems call vilaprisan · ClinicalTrials.gg INT006440
- UNII (FDA) IN59K53GI9VILAPRISANConfirmed FDA, Wikidata
- Wikidata Q27280805vilaprisanConfirmed FDA, Wikidata
- NCI Thesaurus C148505VilaprisanOne source FDA
- DrugBank DB11971One source Wikidata
| System | Code | Name there | Checked by |
|---|---|---|---|
| UNII (FDA) | IN59K53GI9 | VILAPRISAN | Confirmed FDA, Wikidata |
| Wikidata | Q27280805 | vilaprisan | Confirmed FDA, Wikidata |
| NCI Thesaurus | C148505 | Vilaprisan | One source FDA |
| DrugBank | DB11971 | — | One source Wikidata |
“Confirmed” means two independent publishers link the code to this drug; “one source”, one does and its name agrees.